Samantha J. Peterson

November news includes potential Alzheimer treatments, FDA approval of a device to prevent recurrent stroke, & a newly typified headache disorder.

From the social-emotional brain session: how the word ‘fear’ can be misleading, the role of oxytocin in bonding, and frontotemporal dementia.

Data blitz presentations at ANA 2016 featured studies on neuronal dysfunction and degeneration in ALS, Parkinson disease, transverse myelitis, & more.

Award-winning posters presented during the American Neurological Association Annual Meeting discussed risks in stroke, MS, and migraine.

Oct. news includes an approved deep brain stimulation system for movement disorders & biomarkers that improve risk assessment in atrial fibrillation.

Our Sept. news includes a possible clinical marker and therapy target in Alzheimer disease and MS findings from an optical coherence tomography study.

This ECTRIMS session includes studies using 7T and 3T MRI images and translocator protein PET scans, as well as phenotypes in gray matter and more.

Research presented at this ECTRIMS session covered management of multiple sclerosis-related fatigue, cognitive issues, and gait impairment.

Hot Topics session at ECTRIMS 2016: treat early active RRMS with potent induction therapy or immunomodulation then escalation? Where do you stand?

The session featured a study comparing MRI criteria for diagnosing MS, the role of spinal cord volume loss in predicting disease activity, and more.

Our August news includes a potential classification system for Alzheimer disease, new findings in a 3D model of TBI, and migraine treatments.

Our July news includes the Alzheimer-diabetes link, increased rates of Parkinson, and guidelines for acute migraine treatment in the ED.

In a proof-of-concept study, 25 patients were exposed to a dose-escalating infusion of SAGE-547 to evaluate the drug’s effect on essential tremor.

Researchers used simulations to predict the outcomes of epilepsy patients with partial-onset seizures converting to Aptiom monotherapy (800 mg QD).

Research leading up to the ongoing phase 3 trial of SAGE-547, a potential drug for super-refractory status epilepticus, was presented at AAN 2016.

Do you and your patients with epilepsy agree on treatment decisions? A national survey compares AED attribute preferences of patients and neurologists.

Our May news includes memory replay disruption in Alzheimer disease, impulse control disorder in Parkinson disease, and return to play in TBI.

From no evidence of disease activity in MS to studies of a new treatment for periodic paralysis, AAN 2016 featured many exciting clinical trials.

In addition to Guillain-Barré syndrome, a small study from Brazil discussed Zika virus and a possible tie to another autoimmune disorder at AAN 2016.

Two authors of the updated AAN guidelines for treatment with botulinum neurotoxin discussed their findings and potential avenues of further research.

Does traumatic brain injury (TBI) inevitably lead to psychiatric disorders? Research presented at AAN 2016 aimed to quantify the risk of psychiatric illness after TBI.

Neuropsychiatric symptoms are commonly associated with mild cognitive impairment, but does amyloid pathology play a role in this relationship?

In addition to microcephaly, evidence suggests the Zika virus may be linked to another neurological condition, according to a report from the AAN Annual Meeting.

Understanding the relationship between neurological disorders and depression, as shown at AAN 2016, can improve patient outcomes and quality of life.

Using advanced and traditional MRIs, researchers measured the amount of white matter brain damage in living retired NFL players.

Our March news includes benefits of video games in MS & TBI, how a western diet affects Alzheimer disease, and the metabolic syndrome-epilepsy link.

The American Neuropsychiatric Association (ANPA) is holding their 27th Annual Meeting from March 16-19, 2016.

Our Feb. news & research include two new migraine drugs, the stroke-Parkinson link, and the potential of an anticancer drug to prevent Alzheimer.

Our Jan. news & research list includes the possible lingering effects of childhood concussion and the benefits of vitamin D for MS.

Our Dec. news & research list includes groundbreaking research from AES 2015 as well as a few potential neurodegeneration biomarkers.